Donna M. Jacobsen

15.0k total citations · 12 hit papers
33 papers, 10.6k citations indexed

About

Donna M. Jacobsen is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Donna M. Jacobsen has authored 33 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 17 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Donna M. Jacobsen's work include HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (26 papers) and HIV Research and Treatment (17 papers). Donna M. Jacobsen is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (26 papers) and HIV Research and Treatment (17 papers). Donna M. Jacobsen collaborates with scholars based in United States, France and Switzerland. Donna M. Jacobsen's co-authors include Douglas D. Richman, Paul A. Volberding, Scott M. Hammer, Melanie Thompson, Martin Hirsch, Michael S. Saag, Margaret A. Fischl, Patrick Yéni, Robert T. Schooley and Stefano Vella and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Donna M. Jacobsen

33 papers receiving 10.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral Treatment of Adult HIV Infection

2012 1.4k citations Melanie Thompson, Pedro Cahn et al. JAMA profile →
Antiretroviral Therapy in Adults

2000 874 citations Charles C. J. Carpenter, David A. Cooper et al. JAMA profile →
Antiretroviral Therapy for HIV Infection in 1998

1998 837 citations Charles C. J. Carpenter, Margaret A. Fischl et al. JAMA profile →
Antiretroviral Treatment of Adult HIV Infection

2008 832 citations Scott M. Hammer, Joseph J. Eron et al. JAMA profile →
Treatment for Adult HIV Infection

2006 767 citations Scott M. Hammer, Michael S. Saag et al. JAMA profile →
Treatment for Adult HIV Infection

2004 601 citations Patrick Yéni, Scott M. Hammer et al. JAMA profile →
Antiretroviral Treatment of Adult HIV Infection

2010 595 citations Melanie Thompson, Pedro Cahn et al. JAMA profile →
Antiretroviral Treatment for Adult HIV Infection in 2002

2002 573 citations Patrick Yéni, Scott M. Hammer et al. JAMA profile →
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

2016 478 citations Huldrych F. Günthard, Michael S. Saag et al. JAMA profile →
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

2018 401 citations Michael S. Saag, Constance A. Benson et al. JAMA profile →
Antiretroviral Treatment of Adult HIV Infection

2014 352 citations Huldrych F. Günthard, Joseph J. Eron et al. JAMA profile →
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

2022 320 citations Rajesh T. Gandhi, Roger Bedimo et al. JAMA profile →

Peers

Countries citing papers authored by Donna M. Jacobsen

Since Specialization

Citations

This map shows the geographic impact of Donna M. Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna M. Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna M. Jacobsen more than expected).

Fields of papers citing papers by Donna M. Jacobsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna M. Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna M. Jacobsen. The network helps show where Donna M. Jacobsen may publish in the future.

Co-authorship network of co-authors of Donna M. Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Donna M. Jacobsen. A scholar is included among the top collaborators of Donna M. Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna M. Jacobsen. Donna M. Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance 2025 ·Clinical Infectious Diseases ·Annemarie M. J. Wensing, Charlotte Charpentier, Vincent Cálvez, Francesca Ceccherini‐Silberstein, Huldrych F. Günthard, Donna M. Jacobsen, Roger Paredes, Robert W. Shafer, Douglas D. Richman	6
2	Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel 2024 ·Carolina Digital Repository (University of North Carolina at Chapel Hill) ·Brenda Crabtree‐Ramírez, Donna M. Jacobsen, Jennifer Hoy, Susan Buchbinder, Michael S. Saag, Melanie Thompson, Jean‐Michel Molina, Joseph J. Eron, Clara Lehmann, Ellen Eaton, Raphael J. Landovitz, Roger Bedimo, Carlos del Rı́o, Paul E. Sax, Davey M. Smith, Rajesh T. Gandhi, Constance A. Benson, Sandra A. Springer, Huldrych F. Günthard	1
3	Assessing Knowledge of, Experience with, and Willingness to Prescribe Hormone Therapy to Transgender Individuals with HIV: A National Survey of HIV Practitioners 2022 ·Transgender Health ·(unknown), Laramie R. Smith, Donna M. Jacobsen, (unknown), (unknown), Jill Blumenthal	1
4	Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults breakdown → 2022 ·JAMA ·Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, Raphael J. Landovitz, Davey M. Smith, Ellen Eaton, Clara Lehmann, Sandra A. Springer, Paul E. Sax, Melanie Thompson, Constance A. Benson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Michael S. Saag	320
5	Healthcare practitioner experiences and willingness to prescribe pre-exposure prophylaxis in the US 2020 ·PLoS ONE ·Ashley A. Leech, Claus Christiansen, Benjamin P. Linas, Donna M. Jacobsen, (unknown), Mari‐Lynn Drainoni	8
6	Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults breakdown → 2018 ·JAMA ·Michael S. Saag, Constance A. Benson, Rajesh T. Gandhi, Jennifer Hoy, Raphael J. Landovitz, Michael J. Mugavero, Paul E. Sax, Davey M. Smith, Melanie Thompson, Susan Buchbinder, Carlos del Rı́o, Joseph J. Eron, Gerd Fätkenheuer, Huldrych F. Günthard, Jean‐Michel Molina, Donna M. Jacobsen, Paul A. Volberding	401
7	Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults breakdown → 2016 ·JAMA ·Huldrych F. Günthard, Michael S. Saag, Constance A. Benson, Carlos del Rı́o, Joseph J. Eron, Joel E. Gallant, Jennifer Hoy, Michael J. Mugavero, Paul E. Sax, Melanie Thompson, Rajesh T. Gandhi, Raphael J. Landovitz, Davey M. Smith, Donna M. Jacobsen, Paul A. Volberding	478
8	Antiretroviral Treatment of Adult HIV Infection breakdown → 2012 ·JAMA ·Melanie Thompson, (unknown), (unknown), (unknown), (unknown), Pedro Cahn, Joseph J. Eron, Margaret A. Fischl, Scott M. Hammer, Peter Reiss, Douglas D. Richman, (unknown), (unknown), Donna M. Jacobsen, Paul A. Volberding	1364
9	Clinician Attitudes About Commercial Support of Continuing Medical Education 2011 ·Archives of Internal Medicine ·Jeffrey Tabas, Christy Boscardin, Donna M. Jacobsen, Michael A. Steinman, Paul A. Volberding, Robert B. Baron	26
10	Antiretroviral Treatment of Adult HIV Infection breakdown → 2008 ·JAMA ·Scott M. Hammer, Joseph J. Eron, Peter Reiss, Robert T. Schooley, Melanie Thompson, Sharon Walmsley, Pedro Cahn, Margaret A. Fischl, José M. Gatell, Martin Hirsch, Donna M. Jacobsen, Joan Montaner, Douglas D. Richman, Patrick Yéni, Paul A. Volberding	832
11	Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel 2008 ·Clinical Infectious Diseases ·Martin S. Hirsch, Huldrych F. Günthard, Jonathan Schapiro, Françoise Brun‐Vézinet, Bonaventura Clotet, Scott M. Hammer, Victoria A. Johnson, Daniel R. Kuritzkes, John W. Mellors, Deenan Pillay, Patrick Yéni, Donna M. Jacobsen, Douglas D. Richman	375
12	Treatment for Adult HIV Infection breakdown → 2006 ·JAMA ·Scott M. Hammer, Michael S. Saag, Mauro Schechter, Joan Montaner, Robert T. Schooley, Donna M. Jacobsen, Melanie Thompson, Charles C. J. Carpenter, Margaret A. Fischl, Brian Gazzard, José M. Gatell, Martin Hirsch, David Katzenstein, Douglas D. Richman, Stefano Vella, Patrick Yéni, Paul A. Volberding	767
13	Treatment for Adult HIV Infection breakdown → 2004 ·JAMA ·Patrick Yéni, Scott M. Hammer, Martin Hirsch, Michael S. Saag, Mauro Schechter, Charles C. J. Carpenter, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Donna M. Jacobsen, David Katzenstein, Joan Montaner, Douglas D. Richman, Robert T. Schooley, Melanie Thompson, Stefano Vella, Paul A. Volberding	601
14	Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel 2003 ·Clinical Infectious Diseases ·Martin Hirsch, Françoise Brun‐Vézinet, Bonaventura Clotet, Brian Conway, Daniel R. Kuritzkes, Richard T. D’Aquila, Lisa M. Demeter, Scott M. Hammer, Victoria A. Johnson, Clive Loveday, John W. Mellors, Donna M. Jacobsen, Douglas D. Richman	387
15	Antiretroviral Treatment for Adult HIV Infection in 2002 breakdown → 2002 ·JAMA ·Patrick Yéni, Scott M. Hammer, Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Julio Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Thompson, Stefano Vella, Paul A. Volberding	573
16	Toward a Definition of HIV Expertise: A Survey of Experienced HIV Physicians 2001 ·AIDS Patient Care and STDs ·Barbara Gerbert, James C. Moe, Michael S. Saag, Constance A. Benson, Donna M. Jacobsen, (unknown), (unknown), Amy Bronstone, Nona Caspers, Paul A. Volberding	13
17	Antiretroviral Therapy in Adults breakdown → 2000 ·JAMA ·Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Joan Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding	874
18	Antiretroviral Drug Resistance Testing in Adults With HIV Infection 1998 ·JAMA ·Martin Hirsch, Brian Conway, Richard T. D'Aquila, Victoria A. Johnson, Françoise Brun‐Vézinet, Bonaventura Clotet, Lisa M. Demeter, Scott M. Hammer, Donna M. Jacobsen, Daniel R. Kuritzkes, Clive Loveday, John W. Mellors, Stefano Vella, Douglas D. Richman, (unknown)	475
19	Antiretroviral Therapy for HIV Infection in 1998 breakdown → 1998 ·JAMA ·Charles C. J. Carpenter, Margaret A. Fischl, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Julio Montaner, Douglas D. Richman, Michael S. Saag, Robert T. Schooley, Melanie Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding	837
20	HIV viral load markers in clinical practice 1996 ·Nature Medicine ·Michael S. Saag, Mark Holodniy, Daniel R. Kuritzkes, William A. O’Brien, Robert W. Coombs, (unknown), Donna M. Jacobsen, George M. Shaw, Douglas D. Richman, Paul A. Volberding	393

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact